Compounds and Compositions for the Treatment of Ophthalmic Disorders

• 收藏
• 分享

专利权人:

Inc.;Shire Human Genetic Therapies

发明人:

Anneli Savinainen,Mohannad Shawer

申请号：

US15886751

公开号：

US20180215788A1

申请日:

2018.02.01

申请国别(地区):

US

年份:

2018

代理人:

摘要：

Described herein are methods and compositions featuring a first compound that is a linear peptidic NPR-B agonist and a second compound that is a prostaglandin agonist or a β-adrenergic antagonist, which are useful in the treatment and/or prevention of ophthalmic disorders such as glaucoma.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/